Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas J. Garrity currently holds 249,858 shares of ANTARES PHARMA, INC. (ATRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas J. Garrity has been a net seller of ATRS stock. They have purchased $47.5K and sold $1.5M worth of shares.
Thomas J. Garrity's most recent insider trade was on May 24, 2022, when they sold 224,406 shares at $5.60 per share.
Thomas J. Garrity serves as Executive at ANTARES PHARMA, INC. (ATRS). They have executed 72 insider transactions totaling $1.6M over their tenure at the company.
Thomas J. Garrity holds the position of Executive at ANTARES PHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Thomas J. Garrity has shown a selling trading pattern, with $47.5K in total purchases and $1.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas J. Garrity was on May 24, 2022, when they sold $1.3M worth of ATRS shares. This transaction involved 224,406 shares at $5.60 per share.
Thomas J. Garrity currently owns 249,858 shares of ANTARES PHARMA, INC. (ATRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas J. Garrity's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas J. Garrity has 72 Form 4 filings on record as an insider at ANTARES PHARMA, INC..
Set alerts for Thomas J. Garrity and 40,000+ other insiders.